Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114959
Status:
TERMINATED
Last Update Posted:
2015-01-15
First Post:
2005-06-20
Brief Title:
Homoharringtonine With Oral Gleevec in Chronic Accelerated and Blast Phase Chronic Myeloid Leukemia CML
Sponsor:
ChemGenex Pharmaceuticals
Organization:
Teva Branded Pharmaceutical Products RD Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myeloid Leukemia Chronic Chronic-Phase |
| Myeloid Leukemia Chronic |
| Myeloid Leukemia Chronic Accelerated-Phase |
| Blast Phase |
Keywords:
| Name | View |
|---|---|
| Omacetaxine | View |
| ChemGenex Pharmaceuticals Ltd | View |
| ChemGenex Pharmaceuticals | View |
| ChemGenex | View |
| Chronic Myeloid Leukemia | View |
| Myeloid Leukemia Chronic | View |
| Leukemia | View |
| Myeloid Leukemia | View |
| Chronic Phase | View |
| Accelerated Phase | View |
| Blast Phase | View |
| Myeloid Leukemia Chronic Accelerated Phase | View |
| Myeloid Leukemia Chronic | View |
| Leukemia Myeloid Chronic | View |
| Leukemia Myeloid Chronic-Phase | View |
| Leukemia Myeloid Chronic Phase | View |
| Leukemia Myeloid Accelerated-Phase | View |
| Myeloid Leukemia Chronic Chronic Phase | View |
| Leukemia Myeloid Accelerated Phase | View |
| Homoharringtonine | View |